Sequence polymorphism in | |||||||
---|---|---|---|---|---|---|---|
Patient | pvdhfr | Pvdhps | No. of mutations in the 2 genes | Therapeutic responseb | |||
Trial no. | Age (Years) | 33 | 58 | 117 | 383 | ||
VIV7 | 2 | P | S | S | A | 0 | ACPR |
60446 | 2.5 | P | S | S | A | 0 | ACPR |
VIV14 | 7 | L | S | S | A | 1 | ACPR |
VIV18 | 13 | P | S | S | A | 0 | ACPR |
60756 | 42 | P | S | S | A | 0 | ACPR |
VIV3 | 12 | P | R | N | G | 3 | ACPR |
VIV8 | 34 | P | S | N | A | 1 | ACPR |
VIV20 | 9 | P | R | N | A | 2 | TF |
62298 | 5 | P | R | N | A | 2 | ACPR |
60250 | 6 | P | R | N | A | 2 | ACPR |
60149 | 8 | P | R | N | G | 3 | ACPR |
VIV4 | 30 | P | R | N | G | 3 | ACPR |
VIV12 | 6 | P | R | N | G | 3 | TF |
62079 | 0.8 | P | R | N | A | 2 | TF |
VIV15 | 2 | P | R | N | A | 2 | Reinfection or relapse |